Business Wire

CA-ANDERSEN-GLOBAL

Del
Andersen styrker platform i Mellemøsten

Andersen fortsætter med at styrke sin problemfri service til kunder rundt om i verden, og deres brand følger efter, når Andersen Globals medlemsfirmaer i Mellemøsten nu opererer under brandet ”Andersen”. Meddelelsen kommer i forbindelse med optagelsen af brandet ”Andersen” blandt europæiske og latinamerikanske medlemsfirmaer tidligere i år.

Andersen Global-medlemsfirmaer, der tidligere opererede under brands ”Andersen Tax” og ”Andersen Tax & Legal” i Egypten, Jordan og Kuwait går nu over til det fælles brand ”Andersen”. Derudover byder Andersen velkommen til medlemsfirmaet Alrikaz i kongeriet Saudi-Arabien (KSA), som også tager Andersen-brandet til sig. Optagelsen af det fælles brand i regionen reflekterer på bedste vis det fulde omfang af den globale service, som Andersen-medlemsfirmaer tilbyder deres kunder, inklusive juridisk service i 16 lande, hvoraf to er i Mellemøsten.

Udover sine medlemsfirmaer i Egypten, Jordan, Kuwait og KSA er Andersen Global også tilstede i Mellemøsten i Bahrain, Libanon, Oman, Palæstina, Qatar og De Forenede Arabiske Emirater via samarbejdsfirmaer, med planer for fremtidig ekspansion.

”Vores optagelse af et fælles globalt brand viser hvor langt vi er kommet som organisation, og hvor vi er på vej hen”, sagde Mark Vorsatz, Andersen Global Chairman og Andersen CEO. ”Vi er engageret i at skabe en benchmarkingorganisation, som sætter den globale standard for den bedste uafhængige og synergistiske service i sin klasse. Vores fælles brand kendetegner vores problemfri service og delte centrale værdier rundt om i verden.”

Grundlaget for Andersens globale platform går helt tilbage til 2002, hvor 23 tidligere Arthur Andersen-partnere oprettede et firma, der kun beskæftigede sig med skat, WTAS LLC, som efterfulgtes af Andersen Global (tidligere WTAS Global) i 2014. Det samme år tog det grundlæggende amerikanske medlemsfirma brandet ”Andersen Tax” til sig, efterfulgt af medlemsfirmaer i Latinamerika, Europa og Afrika. Andersen Tax og Andersen Tax & Legal debuterede i Mellemøsten i 2017, og regionen er siden blevet udvidet til i dag at omfatte mere end 20 lokationer, 500 medarbejdere indenfor skat og jura, og næsten 100 partnere.

”Mellemøsten er et marked under udvikling, og skattebranchen er i fremgang, med særlig fokus på diversificering af økonomier,” sagde Fouad Al Hourani, Co-Regional Managing Director i Mellemøsten. ”Ved at tilbyde omfattende, problemfrie servicer, inklusive skat og jura, har vi lagt et solidt grundlag, og skabt en konkurrencedygtig platform for vores organisation i regionen.”

Lena Hamdi, Co-Regional Managing Director i Mellemøsten, tilføjer: ”Vores medlemsfirmaers servicetilbud gør os i stand til at opfylde vores kunders behov uanset grænser. Et fælles brand er en milepæl for vores organisation, og vi ser frem til dette næste trin af regionens udvikling.”

I løbet af det næste år fortsætter medlemsfirmaer i Afrika, Canada og Israel med at optage det fælles Andersen-brand, mens Andersen Global fortsætter med at udvide på vigtige markeder, herunder Caribien, Latinamerika, Afrika og Mellemøsten.

Andersen Global er en international sammenslutning af juridisk adskilte, uafhængige medlemsfirmaer bestående af skatte- og juraeksperter fra hele verden. Siden oprettelsen i 2013 af det amerikanske medlemsfirma Andersen Tax LLC har Andersen Global nu over 6.000 eksperter globalt og er repræsenteret på over 214 lokaliteter via sine medlems- og samarbejdsfirmaer.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release

Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde

RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye